Joel S. Marcus - 15 Sep 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Reporting relationship: Director
Issuer ticker: APLT
Reported as of: 15 Sep 2023
Net transaction value: +$12,994
SEC form: 4
Accepted by SEC: 19 Sep 2023, 20:08:34 UTC
Prior SEC filing: 27 Jun 2023
Next SEC filing: 04 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Shoshana Shendelman, as attorney-in-fact

Key filing fact

Joel S. Marcus filed Form 4 for Applied Therapeutics Inc. (APLT) on 19 Sep 2023.

Key facts

This page summarizes Joel S. Marcus's Form 4 filing for Applied Therapeutics Inc. (APLT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 Sep 2023, 20:08.

Change

Previous filing in this sequence was filed on 27 Jun 2023.
Current net transaction value: +$12,994.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APLT transaction

Common Stock

Options Exercise

Transaction value: $12,994
Shares: +12,375
Change %: +2.8%
Price: $1.05
Shares after: 453,414
Date: 15 Sep 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APLT transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -12,375
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Sep 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,375
Exercise price: $1.05
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .